🇺🇸 FDA
Patent

US 7084132

Artemisinins with improved stability and bioavailability for therapeutic drug development and application

granted A61KA61K31/55A61K31/724

Quick answer

US patent 7084132 (Artemisinins with improved stability and bioavailability for therapeutic drug development and application) held by The United States of America as represented by the Secretary of the Army expires Mon Jul 27 2026 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The United States of America as represented by the Secretary of the Army
Grant date
Tue Aug 01 2006 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jul 27 2026 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
15
CPC classes
A61K, A61K31/55, A61K31/724, A61K47/6951